Key Takeaways Pfizer's $7.3B Metsera buyout faces a higher competing offer from Novo Nordisk.PFE has sued Metsera and Novo Nordisk over alleged breach of the merger agreement.Pfizer's new drug pricing deal with the Trump administration provides long-term clarity.On its third-quarter conference call held on Nov. 4, Pfizer (PFE) shed light on the two topics for which it has been in the news lately — the drug pricing deal with the Trump administration and the battle with Novo Nordisk (NVO) related to the Metse ...

公司业绩与事件 - 礼来公司计划在周四早间公布其第三季度财报 [1] - 市场关注焦点在于公司与特朗普政府就减肥药价格达成何种协议 [1]